New-born cells continue to proliferate and survive to become mature granule cells in adult rat hippocampus. Although this process, known as neurogenesis, is inhibited by acute stress, it is not clear whether chronic stress affects neurogenesis. To determine whether chronic mild stress (CMS) influences neurogenesis in the adult rat hippocampus, male Sprague-Dawley rats were exposed to CMS and administered bromodeoxyuridine (BrdU) before or after CMS to observe the survival/differentiation or proliferation of new-born cells, respectively. In addition, we measured brain-derived neurotrophic factor (BDNF) mRNA in the granule cell layer (GCL) of the hippocampus, because BDNF is known to play an important role in the survival of new-born cells. CMS significantly decreased the survival of newborn cells in the GCL, but did not influence the proliferation or differentiation of new-born cells. CMS did not affect the proliferation and survival of new-born cells in the hilus. In addition, CMS did not change BDNF mRNA levels in the GCL. These results demonstrate that CMS reduces the survival of new-born cells but not of their proliferation, suggesting that repeated mild stress could influence a part of neurogenesis, but not the whole part of neurogenesis. These results raise the possibility that the survival of new-born cells may be suppressed in the presence of normal BDNF mRNA levels in GCL.
Introduction
The adult mammalian brain is capable of neurogenesis throughout life, but this is restricted to two major regions in brain: the olfactory bulb and the hippocampus (Cameron et al., 1994; Gould et al., 2002) . A substantial number of new-born cells in subgranular zone (SGZ) of the hippocampus continue to divide and migrate into the granule cell layer (GCL) where they mature into neurons or astrocytes. Hippocampal neurogenesis can be influenced by several environmental factors. It has been demonstrated that stress reduces new-born cell proliferation in the hippocampus (Gould et al., 1997; Tanapat et al., 1998) , whereas treatment with chronic antidepressants increases proliferation (Malberg et al., 2000; Duman et al., 2001) . As a result, repeated stress may contribute to the reduction in hippocampal volume reported in patients with depression (Bremner et al., 2000) in part through reduced neurogenesis in the hippocampus, which could be prevented by chronic antidepressant treatment (Czeh et al., 2001; Li et al., 2004) .
Neurogenesis regulation could occur at several different levels, e.g., by cell proliferation, differentiation, or survival. Several factors play a role in the regulation of neurogenesis, and in particular, neurotrophic factors are known to be critical for the survival of new-born cells during their development in vivo and in culture (Palmer et al., 1997) . Among the factors that are involved in neural and glial differentiation (Aberg et al., 2000; Lee et al., 2003; Kim et al., 2004 ), brain-derived neurotrophic factor (BDNF) is interesting, because it has been shown to promote the differentiation and survival of progenitor cells in the adult brain (Zigova et al., 1998) , and in cultured cells (Vicario-Abejon et al., 1995; Palmer et al., 1997) . In addition, singing behavior has also been reported to increase the expression of BDNF, and this was also found to be correlated with the extent of new Chronic mild stress decreases survival, but not proliferation, of new-born cells in adult rat hippocampus neuron survival (Li et al., 2000) .
It has been demonstrated that chronic stress decreases the proliferation and survival of new-born neurons in the SGZ of the adult tree shrew (Gould et al., 1997) . Moreover, exposure to fox odor was found to inhibit new-born cell proliferation in the hippocampus of adult rats, and this was found to be dependent on stress-induced corticosterone increases (Tanapat et al., 2001) . Consistent with these findings, systemic treatment with corticosterone was found to reduce new-born cell proliferation (Cameron et al., 1994) . Although acute stress was found to decrease new born-cell proliferation (Tanapat et al., 2001; Kim et al., 2005) , it remains unclear as to whether chronic stress influences neurogenesis in the adult rat hippocampus. In the present study, we examined the effects of chronic mild stress (CMS) on the proliferation, differentiation, and survival of new-born cells in the adult rat hippocampus. CMS is one of the validated animal models that imitates anhedonia (one of the two core symptoms in patients with depression) (Stout et al., 2000) . In the present study, rats were given bromodeoxyuridine (BrdU) as a marker of mitotic cells before and after CMS to allow the determination of the survival/differentiation and proliferation of new-born cells in hippocampus, respectively. In addition, we examined the effects of CMS on the expression of BDNF mRNA in the hippocampus.
Materials and Methods

Animals and chronic mild stress exposure
Male Sprague-Dawley rats (initial weight, 150-180 g; n = 6 per group, Samtaco, Osan, Korea) were received 7 d before initiating the CMS procedures, and were housed three per cage under a 12 h lightdark cycle (lights on at 6:00 A.M.). Food and water were available ad libitum except during the food and/or water deprivation periods of the CMS procedures. Rats were exposed to CMS for 19 d from Monday morning, which consisted of the administration of various stressors, as previously described (Moreau et al., 1996; Di Chiara et al., 1999) . The stressors included repeated 1 h periods of confinement to a small cage (24 × 10 × 9 cm), one period of continuous overnight illumination, one overnight period of food and water deprivation followed by 2 h of access to restricted food (3 g per cage), one overnight period of water deprivation followed by 1 h exposure to an empty bottle, one overnight period of group housing (6 rats per cage) in a soiled cage (200 ml of water in sawdust bedding). Animals were also maintained on a reversed light/dark cycle at weekends from Friday (5:00 P.M.) to Monday morning (9:00 A.M.) ( Table 1 ). The last CMS procedure consisted of a reversed light/dark cycle on 19th d (from 5:00 P.M. on the Friday to lights on at 6:00 A.M. on the Saturday). Lights in the animal room were not turned off on this Saturday morning after completing this last CMS procedure. Nonstressed control rats were housed in a separate room and were briefly handled each day without restraint. All procedures used in this study were consistent with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, 1996) .
BrdU treatment
To determine the effect of CMS on cell survival and differentiation, BrdU (Sigma, St. Louis; in 0.9% saline with 0.007 N NaOH) was injected intraperitoneally at 4 × 75 mg/kg every 2 h, and 18 h after the last BrdU injection, rats were exposed to the CMS procedures for 19 d. CMS-exposed rats were perfused at 6-8 h after last CMS procedure, and control animals were perfused midway through the sacrificing of the CMS-exposed rats to reduce time of sacrifice differences. At this survival time, labeled cells had extended axons , survived a period of cell death , and had begun to express mature neuronal markers (Cameron et al., 1993) . To measure the effect of CMS on cell proliferation, rats exposed to CMS were given a single injection of BrdU (100 mg/kg, i.p.) at 4-6 h after the last CMS procedure and were then perfused 2 h later ( Figure 1 ). The 2 h survival time allowed for the incorporation of BrdU into cells due to DNA synthesis, and provided an index of the rate of cell birth at specific times after stress, but not for the completion of mitosis (Nowakowski et al., 1989) or migration (Cameron et al., 1993) .
Histological procedure
Rats were anesthetized with sodium pentobarbital (100 mg/kg, i.p.) and perfused intracardially with 0.9% saline, followed by 4% paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.2 (PPB). Brains were then removed, post-fixed for 12 h, and placed in 20% sucrose/PPB overnight at 4 o C. Serial coronal sections (40 m) were prepared through the hippocampus (bregma -2.12 mm to -6.30 mm, (Paxinos et al., 1997) ) using a freezing microtome (Microm International GMBH, Walldorf, DRG), and stored in a cryoprotectant at -20 o C until required. Every sixth section was incubated with 0.6% H 2 O 2 in phosphatebuffered saline (PBS) for 30 min to block endogenous peroxidase. To denature DNA, sections were incubated in 50% formamide/50% 2 × SSC at 65 o C for 2 h, rinsed in 2 × SSC for 5 min, and then incubated in 2 N HCl at 37 o C for 30 min. Sections were then rinsed for 10 min in 0.1 M sodium borate (pH 8.5), washed with PBS, and incubated for 1 h in PBS containing 0.3% Triton X-100 (PBS-T) followed by 3% normal horse serum at room temperature for 2 h. Thereafter, sections were incubated in monoclonal mouse anti-BrdU antibody (1:500, Roche Diagnostics GmbH, Mannheim, DRG) for 72 h at 4 o C, followed by biotinylated horse anti-mouse IgG (1:500, Vector Laboratories, Burlingame) overnight at 4 o C. After several rinses with PBS-T, the sections were incubated in avidin-biotin-peroxidase complex (1:500, Vector Laboratories) for 3 h at room temperature. Finally, they were incubated in diaminobenzidine solution containing nickel chloride for 10 min, rinsed with PBS, mounted on glass slides, and dried overnight. The slides were counterstained with hematoxylin, dehydrated, and cover-slipped with Permount.
Double-Immunofluorescence
To determine the phenotype of progenitor cells in adult rat hippocampus, double immunofluorescence was conducted to detect the colocalization of BrdU with either calbindin D28k or glial fibrillary acidic protein (GFAP). Calbindin D28k (Kempermann et al., 1997) and GFAP (Cameron et al., 1993) have been used as markers of mature granule neurons and astroglia, respectively. For the fluorescence immunolabeling of phenotypic markers, sections were pretreated as described above, and blocked with 5% normal donkey serum (Jackson Immuno Reaserch, West Grove) in PBS containing 0.3% Triton X-100 (PBS-T) for 1 h at room temperature. After washing in PBS-T, sections were incubated in primary antibody cocktail [either in BrdU (monoclonal, Roche Diagnostics) and calbindin D28k (polyclonal, Chemicon, Temecula), or in BrdU and GFAP ( Immuno Research) for BrdU, and then incubated with rhodamine red-X conjugated streptavidin (Jackson Immuno Research) for rabbit anti-GFAP (Santa Cruz Biotechnology) for 3 h at room temperature. After a rinse in 4 mM sodium carbonate buffer for 15 min at room temperature, sections were washed, and mounted and coverslipped with Gel-Mount (Biomeda, Foster City). To measure the effect of chronic mild stress (CMS) on cell survival, BrdU (75 mg/kg × 4, every 2 h) was given 18 h before the CMS procedures. Rats were subjected to the CMS procedures for 19 d and were perfused 6-8 h after the final CMS stressor. To examine the influence of CMS on the proliferation of BrdU-labeled cells, animals underwent CMS for 19 d and were then given a single dose of BrdU (100 mg/kg) 4-6 h after the final CMS stressor. Animals were sacrificed 2 h after BrdU administration.
Data analysis
In sections processed for BrdU immunohistochemistry alone, staining and cell counting was repeated in two series. All BrdU-labeled cells including individual cells within a cluster, were counted regardless of size or shape on every 12th section throughout the hippocampus (bregma -2.12 mm to -6.30 mm, (Paxinos et al., 1997) ), excluding cells located in the outermost plane of focus, using a light microscope (Nikon Alphaphot-2). Since many SGZ BrdUlabeled cells were found in clusters, individual cells were counted at high magnification (400 × or 1,000 ×). SGZ BrdU-labeled cells that were within two cell body widths of the GCL were considered part of the GCL. Cells that were located more than two cells away from the GCL were classified as being located in the hilar region. For each series, total numbers of GCL and hilar BrdU-labeled cells were multiplied by 12 to obtain an estimate of the total number of BrdU-labeled cells per region. Values for repetitions were averaged. GCL and hilar cell counts were summed to give the total cell number in the dentate gyrus. To determine GCL cross-sectional areas, counterstained GCL was outlined at a magnification of ×100 and areas were measured using the NIH image analysis program (version 1.61). For sections processed for combined immunofluorescence labeling, anatomically matched sections (bregma -3.60 to -3.80 mm) from each brain were analyzed. Immunofluorescence was detected and processed using a confocal laser scanning microscope (Olympus IX70) fitted with an × 20 objective. At least 50 BrdU-positive cells per animal were analyzed using Z-plane sectioning (1 m) to confirm the colocalization of BrdU with phenotype-specific markers. Because BrdU-labeled cells in the hilus rarely express calbindin D28k or GFAP, the numbers of BrdU-labeled cells in GCLs, including the SGZ, that were immunoreactive for either calbindin D28k or GFAP were determined . A minimum of 50 BrdU-labeled cells were measured per brain, and numbers of double-labeled cells were expressed as percentages of the total number of BrdU-labeled cells. Data are expressed as means SEM and subjected to the Student's t-test. Significance was accepted at the P ＜ 0.05 level.
In situ hybridization
Brain tissue sections stored in 4% paraformaldehyde/ 0.1 M phosphate buffer were transferred into a plastic mesh in a 12-well culture plate. The sections were permeabilized with proteinase K (1 g/ml, 37 o C, 30 min), treated with acetic anhydride in 0.1 M triethanolamine (pH 8.0), washed in 2 × SSC (pH 7.0), and then transferred into 500 l of hybridization solution in a 24-well culture plate. The hybridization buffer consisted of 50% formamide, 0.01% polyvinyl pyrrolidone, 0.01% Ficoll, 0.01% bovine serum albumin, 50 g/ml denatured salmon sperm DNA, 250 g/ml yeast tRNA, 40 mM dithiothreitol, 10 % dextran sulfate, and 35S-labeled BDNF cRNA probes at 1 × 10 7 cpm/ml. The sections were hybridized freefloating for 18 h at 55 o C in hybridization solution. After overnight incubation, sections were rinsed for 2 × 30 min at 55 o C in 4 × SSC with 5 mM DTT, treated with RNase A (20 g/ml, 30 min at 45 o C), washed for 4 × 15 min in 2 × SSC containing 5 mM DTT at room temperature. They were then rinsed for 2 × 30 min in 0.5 × SSC containing 5 mM DTT, once for 30 min in 0.1 × SSC containing 5 mM DTT at 50-55 o C, and once in 0.1 × SSC containing 5 mM DTT at room temperature. Sections were mounted onto gelatin-coated microscope slides, and air-dried overnight. They were then exposed to Hyperfilm -max (Amersham Biosciences, Piscataway) for 3-5 d. Levels of BDNF mRNA were determined by outlining regions of interest on in situ hybridization section images and by quantifying densitometrically using an NIH image analysis program (version 1.61). Optical densities were obtained from each hippocampus subfield defined using a stereotaxic atlas (Paxinos et al., 1997) . To correct for nonlinearity, 14 C labeled radioactive standards (Amersham Biosciences, Piscataway) were exposed with tissue sections for calibration purposes. Results are expressed as means ± SEM. Data were subjected to Student's t-test and significance was accepted at the P ＜ 0.05 level.
Results
The effects of CMS on the proliferation of new-born cells in the adult rat hippocampus
To determine whether CMS induces changes in newborn cells in the adult rat hippocampus, rats exposed to CMS for 19 d were given a single injection of BrdU 4-6 h after the final CMS procedure, and then sacrificed 2 h later. BrdU-labeled cells were found to be localized exclusively near the SGZ (the border between the GCL and the hilus) of the hippocampus (Figure 2A ). These cells were darkly stained and irregularly shaped, and were found in clusters ( Figure  2B ). CMS-exposed rats showed no difference from control rats in terms of the number of BrdU-labeled cells in the GCL, hilus, or dentate gyrus ( Figure  3 and 5) . Moreover, no apparent differences in gross morphology and location of these cells were observed within the GCL (control: 78.9%; CMS: 82.9%) or hilus (control: 21.1%; CMS: 17.1%) between control and CMS-exposed rats.
The effects of CMS on the survival of new-born cells in the adult rat hippocampus
To determine whether CMS affects the survival of cells that have already been born in the hippocampus, rats were given four injections of BrdU (4 × 75 mg/kg, i.p.) and then subjected to CMS for 19 d. Rats were sacrificed 6-8 h after the last CMS procedure. Microscopic analysis showed that many BrdU-labeled cells were located in the GCL and that they were indistinguishable in terms of morphology from neighboring granule cells. Some BrdU-labeled cells were round with uniform BrdU nuclear staining throughout the nucleus, whereas other nuclei had a punctate or spotted appearance ( Figure 2E and Rats received BrdU injections 18 h before CMS and were euthanized 6-8 h after the last CMS procedure. The results shown are means ± SEM of BrdU-labeled cells in subregions of the hippocampus (n = 6 per group). Rats subjected to CMS showed a significant decrease in the survival of new-born cells in the dentate gyrus and in GCL relative to control rats. *** P ＜ 0.01 significantly different from control rats. F). No clusters of BrdU-labeled cells were found at this time. CMS significantly decreased the number of BrdU-labeled cells by ~20% in the dentate gyrus and GCL relative to the control (dentate gyrus: control, 9542 ± 357 (mean ± SEM); CMS, 7843 ± 394 (P ＜ 0.01); GCL: control, 8450 ± 256; CMS, 6842 ± 336 (P ＜ 0.01)) (Figure 4 and 5) . In contrast, no difference in the number of BrdU-labeled cells was observed within the hilus in CMS-exposed and control rats (Figure 4) . However, BrdU-labeled cells in CMS-exposed and control rats did not apparently differ in terms of morphology or location within the GCL or hilus ( Figure 6A ). These results suggest that CMS selectively suppresses the survival of newborn cells in adult rat hippocampus, but not cell proliferation, relative to control. To determine whether CMS may influence hippocampal volumes, GCL cross-sectional areas were measured. These crosssectional areas were not significantly different between control and CMS-exposed rats ( Figure 6B ). Although GCL cross-sectional area does not reflect the exact changes in volume, this finding raises the possibility that CMS may not be sufficient or strong enough to change the GCL volume of hippocampus.
The effects of CMS on cellular phenotype in the adult rat hippocampus
To determine the phenotype of mature BrdU-labeled cells, sections were double-labeled for BrdU and for calbindin D28k or GFAP. Confocal microscopy, using z-plane sections to confirm individual cell colocalizations, revealed that ~80% of BrdU-labeled cells in GCL were immunoreactive for calbindin D28k (82.3 ± 1.4 and 84.6 ± 2.6% for control and CMSexposed rats, respectively; Figure 6C and 7A), and that ~15% of BrdU-labeled cells colocalized with GFAP (13.8 ± 2.1 and 14.4 ± 1.8% for control and CMS-exposed rats, respectively, Figure 6C ). The percentage of BrdU-labeled cells that were immunoreactive for either calbindin D28k or GFAP did not differ in control and CMS-exposed rats, indicating that differentiation into either neurons or astroglia may not be affected by CMS. However, it should be mentioned that we selected ~50 BrdU-positive cells in hippocampus per animal to determine the phenotype of BrdU-labeled cells. Thus, it appears that CMS might have not influenced the differentiation of survived cells, although it decreased the survival of new-born cells in hippocampus.
The effects of CMS on BDNF mRNA expression in the adult rat hippocampus BDNF has been reported to be important for neuronal survival during development. Moreover, the expression of BDNF in the hippocampus is known to be down-regulated in response to acute or repeated stress, which raises the possibility that a stress induced decrease in BDNF mRNA expression in the hippocampus may contribute to the suppression of the survival of new-born cells in response to CMS. In the present study, CMS did not change the BDNF mRNA levels in GCL ( Figure 6D and 7A) , indicating that the applied CMS may not be sufficient to reduce BDNF mRNA expression in the GCL.
Discussion
In the present study, to observe the effects of CMS on the survival of new-born cells, BrdU was administered before CMS exposure, and the number of BrdU-labeled cells was determined 19 d later. Under these conditions, the survival of BrdU-labeled cells can be determined independently of the influence of CMS on cell proliferation. The results of the present study demonstrate that CMS reduces the survival of new-born cells in the GCL and dentate gyrus of the adult rat hippocampus. However, in contrast to the reduced survival of new-born cells in the GCL in response to CMS, no difference in proliferation of new-born cells was seen between control and CMS-exposed rats, suggesting that CMS selectively suppress the survival of new-born cells in the hippocampus, but not their proliferation.
Previous studies have shown that acute (Tanapat et al., 1998) and chronic psychosocial stress (Gould et al., 1997) reduces granule cell proliferation. In the present study, the numbers of BrdU-labeled cells in the GCL and dentate gyrus of rats exposed to CMS were similar to those of controls, indicating that CMS did not influence new-born cell proliferation. This result differs from those of previous studies, which showed reduced granule cell proliferation in response to acute (Tanapat et al., 1998) and chronic psychosocial stress (Gould et al., 1997) . However, the present study and these previous reports differ fundamentally e.g., in terms of type of stress, species used, and experimental animal age. We measured plasma corticosterone 6-8 h after the last CMS procedure, but we could not find any significant changes in plasma corticosterone levels between the CMS-exposed rats and nonstressed controls (data not shown). This plasma corticosterone result is in agreement with a previous report, which found that the same procedures of CMS did not change the serum levels of ACTH or corticosterone (Stout et al., 2000) . Thus, if cell proliferation in the adult rat hippocampus is regulated by plasma corticosterone (Cameron et al., 1994) , it appears that no significant change would be expected in cell proliferation in rats exposed to CMS. Interestingly, the present results raise the possibility of a habituation of the hypothalmo-pituitaryadrenal (HPA) axis in response to repeated mild stress. The habituation of HPA axis activation has been previously shown after repeated exposure to restraint (Hauger et al., 1990; Cole et al., 2000) , cold (Bhatnagar et al., 1995) , noise (Armario et al., 1986) , water immersion (De Boer et al., 1990) , and repeated handling (Dobrakovova et al., 1993) .
Interestingly, CMS selectively decreased the survival of new-born cells in GCL and dentate gyrus of the adult rat hippocampus in the present study. The survival of new-born cells in hippocampus has been reported to be influenced by many factors including glucocorticoid and neurotrophins. Prolonged hypothalamo-pituitary-adrenal (HPA) axis activation and the resulting elevation of circulating glucocorticoid levels, observed during stress and aging, have been reported to produce cell death in the hippocampus (Sapolsky, 1996) and evidence conti- nues to suggest that glucocorticoid-induced neuronal death in all these physiological and pathophysiological settings occurs by apoptosis (Reagan et al., 1997) . Moreover, it was reported that BrdU-labeled cells peak at around one week following BrdU injection and then decline over one or two weeks , but no further decrease in BrdUlabeled cells was subsequently observed . Thus, it is possible that glucocorticoid levels were elevated during the early stages of CMS, but not enough to induce habituation during the procedures of CMS, which could lead to suppression of the survival of new-born cells in the adult rat hippocampus. In the present study, we measured plasma corticosterone levels only after CMS procedures, but not during the CMS procedures. It is not clear whether CMS preferentially increases plasma corticosterone during the early stages of CMS despite normal serum levels of ACTH or corticosterone after the same CMS procedures, (Stout et al., 2000) or whether CMS procedures could increase apoptosis of BrdU-labeled cells or preexisting neurons in hippocampus during the CMS procedures. Further study will be needed to clarify the resolution of this question.
In addition to glucocorticoid, in vitro studies have demonstrated that incubation with BDNF increases the differentiation of progenitor cells into neurons, but that it does not directly influence the division of progenitor cells (Palmer et al., 1997) . In vivo studies suggest that singing behavior upregulates the expression of BDNF in a dose-dependant manner, and that this correlates with the extent of new neuron survival (Li et al., 2000) . Moreover, increased apoptosis among hippocampal progenitor cells and excessive neuronal cell death were reported in BDNF knockout mice (Linnarsson et al., 2000) , indicating that BDNF is essential for the survival of neurons, specifically of neuronal populations continuously regenerated in the brain. In addition, acute stress was reported to reduce BDNF expression in the hippocampus (Smith et al., 1995) . These findings suggest that the downregulation of BDNF in response to stress could reduce the neuron differentiation and survival, but not cell proliferation. In the present study, CMS did not change BDNF mRNA levels in GCL. This finding suggests that CMS is insufficient to reduce BDNF mRNA expression in the GCL and that reduced new-born cell survival occurs in the presence of normal BDNF mRNA expression in the GCL. Although we observed no significant changes in BDNF mRNA levels in CMS-exposed rats, BDNF peptide may have been decreased at normal BDNF mRNA levels. However, similar to the plasma corticosterone levels in response to CMS, we cannot rule out the possibility that BDNF may be decreased during early stage CMS, and that this may play an important role in the reduced survival of new-born cells in the adult rat hippocampus. Further studies will be needed to examine possible changes in BDNF peptide or mRNA levels during the CMS procedures. In addition, this result raises the possibility that other factors may be related to decreased new-born cell survival in rats exposed to CMS. One such candidate is insulin-like growth factor-I (IGF-I). Adult rat hippocampal progenitors incubated with IGF-1 not only proliferated faster, but also promoted neuronal lineage from new-born cells (Aberg et al., 2000) . However, it is not known whether stress affects IGF-I levels in the hippocampus. Moreover, in the present study, CMS did not influence the differentiation of BrdU-labeled cells into neurons, raising the possibility that IGF-I levels remained unchanged during the CMS procedures.
Taken together, these results demonstrate that CMS reduces the survival of new-born cells but not of their proliferation, suggesting that repeated mild stress could influence a part of neurogenesis, but not the whole part of neurogenesis. In addition, CMS does not change BDNF mRNA levels in GCL. These results raise the possibility that the survival of new-born cells may be suppressed in the presence of normal BDNF mRNA levels in GCL.
